New
HealthMore in Health→
Nature Medicine Corrects Data in Toripalimab Cancer Trial
Key Takeaways
- The correction updates maintenance-treatment counts and a Figure 2 cutoff date.
- It amends specific adverse-event entries and supplementary-table wording.
- The notice clarifies event and censoring codes in the study source data.
DE
DT Editorial Team··via nature.com